Global Peritoneal Dialysis Tubing Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global Peritoneal Dialysis Tubing market size was valued at US$ 397 million in 2025 and is forecast to a readjusted size of US$ 616 million by 2032 with a CAGR of 6.7% during review period.
Peritoneal Dialysis Tubing generally refers to medical tubing assemblies that safely transfer dialysate between solution bags/warming devices/cycler systems and the patient’s peritoneal access pathway. This includes extension and connection lines used with transfer sets in CAPD, as well as disposable tubing sets designed to interface with automated peritoneal dialysis (APD) cyclers. The core problem it solves is delivering a low-leakage, low-contamination-exposure, and low-use-error fluid pathway under repeated fill-and-drain cycles and frequent connect/disconnect events—often in home settings where user technique can vary—while maintaining stable flow, reliable connections, and design-mediated barriers against microbial ingress, backflow contamination, occlusion, and kink-related access failure. Its evolution mirrors the development of PD therapy models: early PD relied on simpler tubing connections with less consistent infection control, but as CAPD expanded, Y-set and double-bag systems emphasizing reduced touch and reduced open exposure became mainstream, driving tubing from “simple lines” toward more integrated assemblies with clamps, branches, and (depending on design) filtration or valve/check functions. With the growth of APD, tubing sets further converged with cycler interface standards, pumping rhythms, and pressure/flow management requirements, increasing emphasis on assembly precision, fatigue resistance, and batch-to-batch consistency to support stable overnight automated therapy. Upstream materials and components typically include medical-grade thermoplastics and elastomers (e.g., PVC, TPU, TPE, silicone) for extruded tubing with requirements for clarity, flexibility, and kink resistance; precision injection-molded connectors and manifolds (often PP, PC, ABS, or medical copolymers depending on chemical resistance and strength needs); clamps and flow-control elements to reduce misuse; optional filters, drip chambers, and check/valve structures depending on configuration; bonding/welding and sealing materials aligned to solvent bonding, heat sealing, or ultrasonic welding processes; and sterile barrier packaging and sterilization-related materials (medical papers, Tyvek, blister trays, pouches, indicators, and labels). The upstream supply chain is commonly formed by medical resin and compound suppliers, extrusion and tubing-assembly processors, precision molding/tooling specialists, sealing/valve component vendors, sterile packaging suppliers, and sterilization service providers, with final cleanroom assembly, leak/flow consistency testing, packaging qualification, and sterilization release handled by PD consumables manufacturers.In 2025, the global production capacity of peritoneal dialysis catheters reached 7.0 million units, with sales volume totaling 5.127 million units. The average selling price was approximately USD 75.3 per unit, and manufacturers’ gross margins were generally in the range of 20% to 30%.
The PD tubing market is currently defined by strong platform lock-in, high quality thresholds, and a heavy dependence on supply-chain stability to protect clinical confidence. In both CAPD and APD pathways, tubing is tightly coupled with specific connection systems, transfer sets, or cycler interfaces, so providers and patients often prefer to stay within an established platform to minimize adverse-event risk and training burden. As a result, competition is less about “tubing as a commodity” and more about ecosystem performance across the full access workflow. Clinicians focus on sterile connection reliability, seal integrity and fatigue resistance under repeated use, clarity of flow-control elements (clamps/branches/misuse-proofing), and robust lot-to-lot consistency with traceability. Even small process variations can translate into leakage, occlusion, breakage, or contamination exposure, amplifying infection-control concerns and liability pressure. This pushes suppliers to invest in clean manufacturing, precise assembly, rigorous leak testing, and validated packaging/sterilization. Leading players reinforce stickiness through long-term validation, interface standards, and training infrastructure, while regional entrants must first overcome compatibility validation, quality-system maturity, and stable supply capability.
Future development will center on lowering contamination exposure, reducing use errors, improving home usability, and expanding digital management—while differentiating along CAPD versus APD needs. For CAPD, tubing assemblies will continue evolving toward more closed, reduced-touch/reduced-exposure connection concepts, with stronger port protection, clearer connection feedback, and (depending on platform design) backflow prevention or misconnection mitigation to lower the learning curve for new patients. For APD, the emphasis will remain on highly reliable cycler interfaces, stable fluid-path performance, and enhanced cyclic fatigue resistance aligned with more complex overnight therapy rhythms, alongside ongoing improvements in assembly consistency and ease of setup. In parallel, consumable management will shift from compliance-only traceability to operational optimization: UDI/barcode integration with hospital supply systems or home-delivery networks can enable tighter lot control, faster recall response, and closed-loop patient education. In some markets, vendors will increasingly bundle remote training, usage guidance, and follow-up support into broader solution offerings, positioning tubing not just as a consumable but as a pathway-quality enabler.
Key drivers include healthcare systems’ sustained push to expand home dialysis, improve resource efficiency, and enhance patient experience. Nursing constraints and workflow pressure favor standardized, easier-to-train tubing platforms, accelerating adoption where providers can demonstrate safer routines and fewer failures. Guideline and quality-metric attention to peritonitis, access dysfunction, and readmissions further elevates the connection/tubing step as a high-leverage control point. Major constraints include switching resistance created by platform lock-in, compliance-driven change costs, and supply volatility. Once a pathway becomes entrenched, platform switching typically requires substantial training and convincing real-world evidence. Meanwhile, any adjustment to tubing materials, bonding/welding processes, sterilization methods, or packaging structures can trigger revalidation and regulatory change-control burden, slowing iteration. Finally, fluctuations in key resins and additives, precision molded components, and sterilization/sterile packaging capacity can disrupt deliveries and undermine confidence—becoming a practical barrier to rapid scaling, especially for newer entrants.
This report is a detailed and comprehensive analysis for global Peritoneal Dialysis Tubing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Peritoneal Dialysis Tubing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Peritoneal Dialysis Tubing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Peritoneal Dialysis Tubing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Peritoneal Dialysis Tubing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peritoneal Dialysis Tubing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peritoneal Dialysis Tubing market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Fresenius, Baxter, US rental care, B.Braun, Diaverum, Nipro Corporation, Asahi Kasei, Nikkiso, Toray, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Peritoneal Dialysis Tubing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Straight Tube
Bend Tube
Others
Market segment by Material
Silicone
Polyurethane
Surface Modification Materials
Market segment by Application
Hospital
Clinic
Major players covered
Medtronic
Fresenius
Baxter
US rental care
B.Braun
Diaverum
Nipro Corporation
Asahi Kasei
Nikkiso
Toray
WEGO group
Merit Medical
PFM Medical
AMECATH
AdvinHealthcare
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peritoneal Dialysis Tubing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peritoneal Dialysis Tubing, with price, sales quantity, revenue, and global market share of Peritoneal Dialysis Tubing from 2021 to 2026.
Chapter 3, the Peritoneal Dialysis Tubing competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peritoneal Dialysis Tubing breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Peritoneal Dialysis Tubing market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peritoneal Dialysis Tubing.
Chapter 14 and 15, to describe Peritoneal Dialysis Tubing sales channel, distributors, customers, research findings and conclusion.